Anumana, an AI-driven health technology leader and a portfolio company of nference, has announced significant advancements in pulmonary hypertension (PH) diagnosis through its latest study, revealing promising results for its investigational PH algorithm. The study, titled “An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension,” was published in the European Respiratory Journal, showcasing the […]
Gradient Denervation Technologies has successfully closed a €14 million Series A financing round to support the clinical development of its ultrasound-based catheter device for pulmonary hypertension treatment. The funding round was led by Asabys Partners through its new fund Sabadell Asabys II and saw participation from Thuja Capital and founding investor Sofinnova Partners. Gradient Denervation […]
Viz.ai, a frontrunner in artificial intelligence (AI) powered disease detection and intelligent care coordination, has inked an exclusive agreement with the University of California, San Francisco (UCSF) to commercialize three AI algorithms. Developed by leading researchers at UCSF, these algorithms aim for the automated detection of cardiovascular diseases, including cardiac amyloidosis, pulmonary hypertension, and supraventricular […]
Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the United States Food and Drug Administration (FDA). According to Zydus Lifesciences, Sildenafil for oral suspension is approved for the treatment of high blood pressure in the lungs (pulmonary hypertension). By […]
